Analysen von Richard Vosser
| 04.12.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 03.12.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 03.12.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 03.12.24 | Bayer Neutral | JP Morgan Chase & Co. | |
| 03.12.24 | Merck Overweight | JP Morgan Chase & Co. | |
| 03.12.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 03.12.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 03.12.24 | Sanofi Neutral | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 03.12.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 03.12.24 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 21.11.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 18.11.24 | Merck Overweight | JP Morgan Chase & Co. | |
| 15.11.24 | Bayer Neutral | JP Morgan Chase & Co. | |
| 14.11.24 | Merck Overweight | JP Morgan Chase & Co. | |
| 12.11.24 | Bayer Neutral | JP Morgan Chase & Co. | |
| 12.11.24 | Merck Overweight | JP Morgan Chase & Co. | |
| 11.11.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 11.11.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 07.11.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 07.11.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 06.11.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 04.11.24 | Merck Overweight | JP Morgan Chase & Co. | |
| 01.11.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 30.10.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 30.10.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 29.10.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 29.10.24 | Merck Overweight | JP Morgan Chase & Co. | |
| 28.10.24 | Bayer Neutral | JP Morgan Chase & Co. | |
| 25.10.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 25.10.24 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 23.10.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 21.10.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 21.10.24 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 18.10.24 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 18.10.24 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 18.10.24 | Merck Overweight | JP Morgan Chase & Co. | |
| 17.10.24 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 17.10.24 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 17.10.24 | Merck Overweight | JP Morgan Chase & Co. | |
| 15.10.24 | Bayer Neutral | JP Morgan Chase & Co. | |
| 14.10.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 07.10.24 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 03.10.24 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 01.10.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 30.09.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 27.09.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 27.09.24 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 26.09.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 20.09.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 20.09.24 | Sanofi Neutral | JP Morgan Chase & Co. | |